HAPVY.US Hapvida Participações e Investimentos S.A.
- Market cap
- USD 603M
- P/E
- -
- P/B
- 0.07x
- ROE
- -0.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HAPVY.US undervalued?
Graham numberThe Graham number of Hapvida Participações e Investimentos S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hapvida Participações e Investimentos S.A. fundamental analysis
No fundamental analysis for Hapvida Participações e Investimentos S.A. yet.
Hapvida Participações e Investimentos S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hapvida Participações e Investimentos S.A.
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil.
Full company profileHapvida Participações e Investimentos S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hapvida Participações e Investimentos S.A. annual financial statements (BRL; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 9.88B | 23.7B | 27.9B | 28.9B | 31.6B | 32.7B |
| Gross Profit | 3.07B | 5.66B | 3.18B | 3.30B | 3.72B | 4.54B |
| Operating Income | 637M | 49.1M | 1.69B | 1.73B | 1.91B | 2.81B |
| EBITDA | - | 2.35B | 3.37B | 3.31B | 4.05B | 4.10B |
| Net Income | 498M | -777M | -615M | -649M | -142M | -102M |
| EPS | 0.13 | -0.11 | -0.08 | -0.09 | -0.30 | -0.21 |
| Balance Sheet | ||||||
| Total Assets | 21.4B | 72.0B | 73.2B | 73.5B | 72.3B | 73.3B |
| Total Liabilities | 10.8B | 22.7B | 23.5B | 24.8B | 24.0B | 25.0B |
| Shareholders' Equity | 10.6B | 49.3B | 49.7B | 48.7B | 48.2B | 48.2B |
| Cash & Short-term Investments | 347M | 1.27B | 1.43B | 597M | 875M | 611M |
| Cash Flow | ||||||
| Operating Cash Flow | 252M | 972M | 2.33B | 2.73B | 2.09B | 2.00B |
| Capital Expenditure | 708M | 212M | 244M | 293M | 0.00 | 358M |
| Free Cash Flow | -457M | 760M | 2.09B | 2.43B | 2.09B | 1.72B |
| Ratios | ||||||
| ROE | 4.7% | -1.6% | -1.2% | -1.3% | -0.3% | -0.2% |
| ROA | 2.3% | -1.1% | -0.8% | -0.9% | -0.2% | -0.1% |
| Net Profit Margin | 5.0% | -3.3% | -2.2% | -2.2% | -0.4% | -0.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Hapvida Participações e Investimentos S.A. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | BRL 1.02B | 0.14 | - |
| 2021 | BRL 285M | 0.07 | 57.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 0.266667:1 on Jun 9, 2025.
Who owns Hapvida Participações e Investimentos S.A.
Ownership data of Hapvida Participações e Investimentos S.A. is not available yet.
Hapvida Participações e Investimentos S.A. company profile
- Company name
- Hapvida Participações e Investimentos S.A.
- Ticker
- HAPVY.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Insurance - Life
- Fiscal year end
- December
- Address
- Av. Heráclito Graça, no. 406, Fortaleza, CE, Brazil
- Phone
- 55 85 2559 010
- Website
- ri.hapvida.com.br
About Hapvida Participações e Investimentos S.A.
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil.
Hapvida Participações e Investimentos S.A. management
10- Mr. Luccas Augusto AdibStatutory Chief Executive Officer & Member of Executive Board
- Mr. Lucas Álvares Martin GarridoStatutory CFO & Member of Board of Executive Officers
- Alain BenvenutiChief Commercial Officer & Member of Management Board
- Mr. Gustavo Henrique Zacharias RibeiroChief of Institutional Relations Officer & Member of Board of Executive Officers · born 1977
- Rafael AndradeVice-President Commercial & Member of Board of Executive Officers
- Ms. Cideria Barbosa da CostaStatutory Chief of Operations Officer & Member of Executive Board
- Felipe AraújoChief of Human Resources, Diversity and Sustainability Officer & Member of Board of Exe. Officers
- Bernardo MarottaChief of Dental and Marketing Officer & Member of Board of Executive Officers
- Nicolau CamargoChief of Client Officer & Member of Board of Executive Officers
- Mr. Daniel VidottiCIO, VP of Technology & Member of Executive Board